What You Should Know:
- Artera, a company developing multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the publication of a significant validation study in the JCO Clinical Cancer Informatics.
- The study rigorously assessed
Read More
AI Study Challenges Fears of Racial Bias in Prostate Cancer Care
